These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31437404)

  • 1. Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.
    Bogaard HJ; Legchenko E; Chaudhary KR; Sun XQ; Stewart DJ; Hansmann G
    Am J Respir Crit Care Med; 2019 Dec; 200(11):1447-1450. PubMed ID: 31437404
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Bogaard
    Kojonazarov B; Hadzic S; Ghofrani HA; Grimminger F; Seeger W; Weissmann N; Schermuly RT
    Am J Respir Crit Care Med; 2019 Dec; 200(11):1450-1452. PubMed ID: 31437400
    [No Abstract]   [Full Text] [Related]  

  • 3. The Adult Sprague-Dawley Sugen-Hypoxia Rat Is Still "the One:" A Model of Group 1 Pulmonary Hypertension: Reply to Le Cras and Abman.
    Bogaard HJ; Legchenko E; Ackermann M; Kühnel MP; Jonigk DD; Chaudhary KR; Sun X; Stewart DJ; Hansmann G
    Am J Respir Crit Care Med; 2020 Mar; 201(5):621-624. PubMed ID: 31769697
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of the thromboxane receptor antagonist NTP42 alone, or in combination with sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension.
    Mulvaney EP; Reid HM; Bialesova L; Mendes-Ferreira P; Adão R; Brás-Silva C; Kinsella BT
    Eur J Pharmacol; 2020 Dec; 889():173658. PubMed ID: 33121950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Sugen 5416/Hypoxia Mouse Model of Pulmonary Arterial Hypertension.
    Bueno-Beti C; Hadri L; Hajjar RJ; Sassi Y
    Methods Mol Biol; 2018; 1816():243-252. PubMed ID: 29987825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RP5063, a novel, multimodal, serotonin receptor modulator, prevents Sugen 5416-hypoxia-induced pulmonary arterial hypertension in rats.
    Bhat L; Hawkinson J; Cantillon M; Reddy DG; Bhat SR; Laurent CE; Bouchard A; Biernat M; Salvail D
    Eur J Pharmacol; 2017 Sep; 810():83-91. PubMed ID: 28576407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Emphysema in the SU5416/Hypoxia Rat Model of Pulmonary Hypertension.
    Kojonazarov B; Hadzic S; Ghofrani HA; Grimminger F; Seeger W; Weissmann N; Schermuly RT
    Am J Respir Crit Care Med; 2019 Aug; 200(4):515-518. PubMed ID: 31034778
    [No Abstract]   [Full Text] [Related]  

  • 8. Mesenchymal Stem Cell Extracellular Vesicles Reverse Sugen/Hypoxia Pulmonary Hypertension in Rats.
    Klinger JR; Pereira M; Del Tatto M; Brodsky AS; Wu KQ; Dooner MS; Borgovan T; Wen S; Goldberg LR; Aliotta JM; Ventetuolo CE; Quesenberry PJ; Liang OD
    Am J Respir Cell Mol Biol; 2020 May; 62(5):577-587. PubMed ID: 31721618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Disruption of VEGF Receptor Signaling and the Risk for Adult Emphysema.
    Le Cras TD; Abman SH
    Am J Respir Crit Care Med; 2020 Mar; 201(5):620-621. PubMed ID: 31769719
    [No Abstract]   [Full Text] [Related]  

  • 10. Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.
    Kato F; Sakao S; Takeuchi T; Suzuki T; Nishimura R; Yasuda T; Tanabe N; Tatsumi K
    Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L899-L915. PubMed ID: 28798259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Sugen/Hypoxia Rat Model for Pulmonary Hypertension and Right Heart Failure.
    Bikou O; Sassi Y
    Methods Mol Biol; 2024; 2803():163-172. PubMed ID: 38676892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selective PGI2 receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats.
    Honda Y; Kosugi K; Fuchikami C; Kuramoto K; Numakura Y; Kuwano K
    PLoS One; 2020; 15(10):e0240692. PubMed ID: 33057388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Aryl Hydrocarbon Receptor in Sugen 5416-induced Experimental Pulmonary Hypertension.
    Dean A; Gregorc T; Docherty CK; Harvey KY; Nilsen M; Morrell NW; MacLean MR
    Am J Respir Cell Mol Biol; 2018 Mar; 58(3):320-330. PubMed ID: 28956952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
    Park JF; Clark VR; Banerjee S; Hong J; Razee A; Williams T; Fishbein G; Saddic L; Umar S
    Circ Heart Fail; 2021 Feb; 14(2):e007058. PubMed ID: 33541093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetrance of Severe Pulmonary Arterial Hypertension in Response to Vascular Endothelial Growth Factor Receptor 2 Blockade in a Genetically Prone Rat Model Is Reduced by Female Sex.
    Chaudhary KR; Deng Y; Yang A; Cober ND; Stewart DJ
    J Am Heart Assoc; 2021 Aug; 10(15):e019488. PubMed ID: 34315227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treprostinil palmitil inhibits the hemodynamic and histopathological changes in the pulmonary vasculature and heart in an animal model of pulmonary arterial hypertension.
    Corboz MR; Plaunt AJ; Malinin V; Li Z; Gauani H; Chun D; Cipolla D; Perkins WR; Chapman RW
    Eur J Pharmacol; 2022 Feb; 916():174484. PubMed ID: 34508752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat model.
    Lu M; Chen LY; Gairhe S; Mazer AJ; Anderson SA; Nelson JNH; Noguchi A; Siddique MAH; Dougherty EJ; Zou Y; Johnston KA; Yu ZX; Wang H; Wang S; Sun J; Solomon SB; Vanderpool RR; Solomon MA; Danner RL; Elinoff JM
    Am J Physiol Lung Cell Mol Physiol; 2022 Mar; 322(3):L315-L332. PubMed ID: 35043674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CrossTalk proposal: The mouse SuHx model is a good model of pulmonary arterial hypertension.
    Penumatsa KC; Warburton RR; Hill NS; Fanburg BL
    J Physiol; 2019 Feb; 597(4):975-977. PubMed ID: 30499212
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of mitochondrial fragmentation in microvascular endothelial cells isolated from the SU5416/hypoxia model of pulmonary arterial hypertension.
    Suresh K; Servinsky L; Jiang H; Bigham Z; Zaldumbide J; Huetsch JC; Kliment C; Acoba MG; Kirsch BJ; Claypool SM; Le A; Damarla M; Shimoda LA
    Am J Physiol Lung Cell Mol Physiol; 2019 Nov; 317(5):L639-L652. PubMed ID: 31461316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.
    Oka M; Homma N; Taraseviciene-Stewart L; Morris KG; Kraskauskas D; Burns N; Voelkel NF; McMurtry IF
    Circ Res; 2007 Mar; 100(6):923-9. PubMed ID: 17332430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.